Open access
81
Views
8
CrossRef citations to date
0
Altmetric
Original Research
Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US
Krithika Rajagopalan1 Sunovion Pharmaceuticals Inc., Marlborough, MA 01752, USA, [email protected]
, Lisa Bloudek2 Curta Inc., Seattle, WA 98116, USA
, Jessica Marvel3 Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA
, Carole Dembek1 Sunovion Pharmaceuticals Inc., Marlborough, MA 01752, USA, [email protected]Correspondence[email protected]
& Abhishek Kavati3 Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA
Pages 3867-3877
|
Published online: 28 Nov 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.